BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 9033197)

  • 1. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Dec; 58(4):325-37. PubMed ID: 3323750
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary dapsone resistance in Bamako and Chingleput: final report; THELEP. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Sep; 58(3):209-18. PubMed ID: 3312895
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of patients in the THELEP trials of chemotherapy of leprosy at Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Mar; 58(1):7-16. PubMed ID: 3298905
    [No Abstract]   [Full Text] [Related]  

  • 5. The THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP). Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):864-71. PubMed ID: 3325580
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP; Malta AM; Sarno EN; Kaplan G
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of the multiplication of dapsone-resistant strains of Mycobacterium leprae in mice. Subcommittee on Clinical Trials of the C hemotherapy of Leprosy (THELEP) Scientific Working Group of UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1988 Mar; 59(1):5-10. PubMed ID: 3294541
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
    Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
    Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I; Dogra S; Kumar B; Radotra BD
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapses in multibacillary leprosy patients after stopping treatment with rifampin-containing combined regimens. Marchoux Chemotherapy Study Group.
    Jamet P; Ji B
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):525-35. PubMed ID: 1299707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of MDT in multibacillary leprosy.
    Jesudasan K; Vijayakumaran P; Manimozhi N; Rao PS; Samuel P
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):128-32. PubMed ID: 8690970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea.
    Cellona RV; Fajardo TT; Kim DI; Hah YM; Ramasoota T; Sampattavanich S; Carrillo MP; Abalos RM; dela Cruz EC; Ito T
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):1-11. PubMed ID: 2181040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-centre, double blind, randomized trial of three steroid regimens in the treatment of type-1 reactions in leprosy.
    Rao PS; Sugamaran DS; Richard J; Smith WC
    Lepr Rev; 2006 Mar; 77(1):25-33. PubMed ID: 16715687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.